PARAPLATIN INJ 150MG/VIAL DIN 00680060
Status: Cancelled Post Market
Holder: BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
Molecule: CARBOPLATIN
Health Canada record
| Active ingredient(s) | CARBOPLATIN 150 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XA02 CARBOPLATIN |
| Original market date | 31-Dec-1986 |
| Current status date | 09-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CARBOPLATIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02528916 | CARBOPLATIN INJECTION | AURO PHARMA INC | Solution | CARBOPLATIN 10 MG | Approved |
| 02125439 | CARBOPLATIN INJECTION | TEVA CANADA LIMITED | Solution | CARBOPLATIN 10 MG | Marketed |
| 02535289 | CARBOPLATIN INJECTION | EUGIA PHARMA INC. | Solution | CARBOPLATIN 10 MG | Approved |
| 02126680 | CARBOPLATIN INJECTION BP | PFIZER CANADA ULC | Solution | CARBOPLATIN 10 MG | Marketed |
| 02570963 | CARBOPLATIN INJECTION BP | MARCAN PHARMACEUTICALS INC | Solution | CARBOPLATIN 10 MG | Approved |
| 02320371 | CARBOPLATIN INJECTION BP | ACCORD HEALTHCARE INC | Solution | CARBOPLATIN 10 MG | Marketed |
| 02420228 | CARBOPLATIN INJECTION, BP | STRIDES PHARMA CANADA INC | Solution | CARBOPLATIN 10 MG | Approved |
| 02366053 | CARBOPLATIN INJECTION | OMEGA LABORATORIES LIMITED | Solution | CARBOPLATIN 10 MG | Dormant |
| 01990438 | CARBOPLATIN INJECTION LIQ 10MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | CARBOPLATIN 10 MG | Cancelled Post Market |
| 00788759 | PARAPLATIN-AQ INJ 10MG/ML | BRISTOL-MYERS SQUIBB CANADA | Liquid | CARBOPLATIN 10 MG | Cancelled Post Market |
International API supply for CARBOPLATIN
11 valid EDQM Certificates of Suitability from 11 holders. 11 active FDA Drug Master Files.
Request a quote for PARAPLATIN INJ 150MG/VIAL